
Blood biomarkers reveal which glioblastoma patients respond to Delta-24-RGD oncolytic virus plus IFN-γ, guiding personalized dosing and survival.
Chibawanye Ene, MD, PhD, is an assistant professor and physician-scientist in the Department of Neurosurgery at MD Anderson Cancer Center.

Blood biomarkers reveal which glioblastoma patients respond to Delta-24-RGD oncolytic virus plus IFN-γ, guiding personalized dosing and survival.